Skip to main content

Table 3 First-line tuberculosis treatment-related conditions in MDR-TB cases and their controls in Addis Ababa, 2011

From: Determinants of multidrug-resistant tuberculosis in patients who underwent first-line treatment in Addis Ababa: a case control study

Characteristics

Cases

Controls

(n = 134)

(n = 134)

 

Number

Percentage

Number

Percentage

Encountered drug side effect

No

67

50.0

109

81.3

Yes

67

50.0

25

18.7

Suffered the most common drug side effect (vomiting)

No

85

63.4

124

92.5

Yes

49

36.6

10

7.5

Duration of first-time TB treatment

2–4 months

3

2.2%

1

0.75%

5–7 months

22

16.4%

2

1.5%

8 months

103

76.9%

128

95.5

9–13 months

6

4.5%

3

2.2%

Directly observed by health worker while taking anti-TB

No

65

48.5

7

5.2

Yes

69

51.5

127

94.8

If yes, how many months

1–2 weeks

11

15.95

0

0

One month

32

46.4

1

0.8

Two months

26

37.7

126

99.2

Reason for interruption for at least a day

Side effects

34

36.6

3

30.0

Forgot to take it

23

24.7

7

70.0

Symptoms were gone and felt good

29

31.2

0

0

Shortage of drug

7

7.5

0

0

Ever interrupted anti-TB for at least a day

No

41

30.6

124

92.5

Yes

93

69.4

10

7.5

Took the medication at a regular time

No

81

60.5

25

18.7

Yes

53

39.5

109

81.3

Outcome of first anti-TB treatment

Treatment success

64

47.7

132

98.5

Defaulted

16

11.9

2

1.5

Treatment failure

54

40.3

0

0

Drug regimen (category) for the second time

Category II

101

94.4

3

23.1

Category I

6

5.6

10

76.9